Correlation Between Opus Genetics, and VSee Health,

Can any of the company-specific risk be diversified away by investing in both Opus Genetics, and VSee Health, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opus Genetics, and VSee Health, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Opus Genetics, and VSee Health,, you can compare the effects of market volatilities on Opus Genetics, and VSee Health, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opus Genetics, with a short position of VSee Health,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opus Genetics, and VSee Health,.

Diversification Opportunities for Opus Genetics, and VSee Health,

0.14

Correlation Coefficient

Opus Genetics,  VSee Health,

Average diversification

The 3 months correlation between Opus and VSee is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Opus Genetics, and VSee Health, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VSee Health, and Opus Genetics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opus Genetics, are associated (or correlated) with VSee Health,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VSee Health, has no effect on the direction of Opus Genetics, i.e., Opus Genetics, and VSee Health, go up and down completely randomly.

Pair Corralation between Opus Genetics, and VSee Health,

Considering the 90-day investment horizon Opus Genetics, is expected to under-perform the VSee Health,. But the stock apears to be less risky and, when comparing its historical volatility, Opus Genetics, is 1.08 times less risky than VSee Health,. The stock trades about -0.08 of its potential returns per unit of risk. The VSee Health, is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest  169.00  in VSee Health, on September 26, 2024 and sell it today you would lose (36.00) from holding VSee Health, or give up 21.3% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Opus Genetics,  vs.  VSee Health,

Opus Genetics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Opus Genetics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

VSee Health,

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in VSee Health, are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, VSee Health, may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Opus Genetics, and VSee Health,

The main advantage of trading using opposite Opus Genetics, and VSee Health, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opus Genetics, position performs unexpectedly, VSee Health, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VSee Health, will offset losses from the drop in VSee Health,'s long position.

The idea behind Opus Genetics, and VSee Health, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.